Analysis of a temperature-sensitive vaccinia virus mutant in the viral mRNA capping enzyme isolated by clustered charge-to-alanine mutagenesis and transient dominant selection

Virology

Volumn 238, Issue 2, 1997, Pages 391-409

  Hassett, Daniel E ^a   Lewis, Jackie I ^a   Xing, Xuekun ^b   Delange, Luke ^b   Condit, Richard C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLTRANSFERASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; ENZYME ISOLATION; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; VACCINIA VIRUS; VIRION; VIRUS GENOME;

EID: 0031585560     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8820     Document Type: Article

References (70)

1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1987;Wiley, New York.
2. Baldick C. J. Jr., Keck J. G., Moss B. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J. Virol. 66:1992;4710-4719.
3. Baroudy B. M., Moss B. Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J. Biol. Chem. 255:1980;4372-4380.
4. Bayliss C. D., Condit R. C. Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. Virology. 194:1993;254-262.
5. Bennett W. F., Paoni N. F., Keyt B. A., Botstein D., Jones A. J. S., Presta L., Wurm F. M., Zoller M. J. High resolution analysis of functional determinants on human tissue-type plasminogen activator. J. Biol. Chem. 266:1991;5191-5201.
6. Black E. P., Condit R. C. Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor. J. Virol. 70:1996;47-54.
7. Carpenter M. S., Delange A. M. A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J. Virol. 65:1991;4042-4050.
8. Condit R. C., Motyczka A. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology. 113:1981;224-241.
9. Condit R. C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology. 128:1983;429-443.
10. Condit R. C., Lewis J. I., Quinn M., Christen L. M., Niles E. G. Use of lysolecithin-permeabilized infected-cell extracts to investigate thein vitro. Virology. 218:1996;169-180.
11. Cong P., Shuman S. Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme. J. Biol. Chem. 267:1992;16424-16429.
12. Cong P., Shuman S. Covalent catalysis in nucleotidyl transfer. A KTDG motif essential for enzyme-GMP complex formation by mRNA capping enzyme is conserved at the active sites of RNA and DNA ligases. J Biol. Chem. 268:1993;7256-7260.
13. Cong P., Shuman S. Mutational analysis of mRNA capping enzyme identifies amino acids involved in GTP binding, enzyme-guanylate formation, and GMP transfer to RNA. Mol. Cell. Biol. 15:1995;6222-6231.
14. Cooper J. A., Wittek R., Moss B. Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs. J. Virol. 39:1981;733-745.
15. Dales S., Mosbach E. Vaccinia as a model for membrane biogenesis. Virology. 35:1968;546-583.
16. Dales S., Siminovitch L. The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy. J. Biophys. Biochem. Cytol. 10:1961;475-503.
17. Dales S., Milovanovitch V., Pogo B. G., Weintraub S. B., Huima T., Wilton S., McFadden G. Biogenesis of vaccinia: Isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology. 84:1978;403-428.
18. Delange A. M. Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome. J. Virol. 63:1989;2437-2444.
19. Delange A. M., McFadden G. Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence. J. Virol. 61:1987;1957-1963.
20. Delange A. M., McFadden G. The role of telomeres in poxvirus DNA replication. Curr. Top. Microbiol. Immunol. 163:1990;71-92.
21. Delange A. M., Carpenter M. S., Choy J., Newsway V. E. An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase. J Virol. 69:1995;2082-2091.
22. Diamond S. E., Kirkegaard K. Clustered charge-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis. J. Virol. 68:1993;863-876.
23. Ensinger M. J., Moss B. Modification of the 5′ terminus of mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells. J Biol. Chem. 251:1976;5283-5291.
24. Ensinger M. J., Martin S. A., Paoletti E., Moss B. Modification of the 5′-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus. Proc. Natl. Acad. Sci. USA. 72:1975;2525-2529.
25. Falkner F. G., Moss B. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:1990;3108-3111.
26. Garces J., Masternak K., Kunz B., Wittek R. Reactivation of transcription from a vaccinia virus early promoter late in infection. J. Virol. 67:1993;5394-5401.
27. Gershowitz A., Moss B. Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated. J. Virol. 31:1979;849-853.
28. Guo P. X., Moss B. Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed inEscherichia coli. Proc. Natl. Acad. Sci. USA. 87:1990;4023-4027.
29. Hassett D. E., Condit R. C. Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine. Proc. Natl. Acad. Sci. USA. 91:1994;4554-4558.
30. Higman M. A., Niles E. G. Location of theSL. J Biol. Chem. 269:1994;14982-14987.
31. Higman M. A., Bourgeois N., Niles E. G. The vaccinia virus mRNA (guanine-N7-)-methyltransferase requires both subunits of the mRNA capping enzyme for activity. J. Biol. Chem. 267:1992;16430-16437.
32. Higman M. A., Christen L. A., Niles E. G. The mRNA (guanine-7-)methyltransferase domain of the vaccinia virus mRNA capping enzyme: Expression inEscherichia coli. J Biol. Chem. 269:1994;14974-14981.
33. Hu F. Q., Pickup D. J. Transcription of the terminal loop region of vaccinia virus DNA is initiated from the telomere sequences directing DNA resolution. Virology. 181:1991;716-720.
34. Hu X., Carroll L. J., Wolffe E. J., Moss B. De novo. J Virol. 70:1996;7669-7677.
35. Joklik W. K. Purification of four strains of poxvirus. Virology. 18:1962;9-18.
36. Keck J. G., Baldick C. J., Moss B. Role of DNA replication in vaccinia virus gene expression: A naked template is required for transcription of three late trans-activator genes. Cell. 61:1990;801-809.
37. Luo Y., Mao X., Deng L., Cong P., Shuman S. The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme. J Virol. 69:1995;3852-3856.
38. Mahr A., Roberts B. E. Arrangement of late RNAs transcribed from a 7.1-kilobaseEco. J. Virol. 49:1984;510-520.
39. Mao X., Shuman S. Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit: Identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer. J Biol. Chem. 269:1994;24472-24479.
40. Mao X., Shuman S. Vaccinia virus mRNA (guanine-7-)methyltransferase: Mutational effects on cap methylation and AdoHcy-dependent photo-cross-linking of the cap to the methyl acceptor site. Biochemistry. 35:1996;6900-6910.
41. Martin S. A., Paoletti E., Moss B. Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions. J. Biol. Chem. 250:1975;9322-9329.
42. Merchlinsky M. Mutational analysis of the resolution sequence of vaccinia virus DNA: Essential sequence consists of two separate AT-rich regions highly conserved among poxviruses. J. Virol. 64:1990;5029-5035.
43. Merchlinsky M., Moss B. Nucleotide sequence required for resolution of the concatemer junction of vaccinia virus DNA. J. Virol. 63:1989a;4354-4361.
44. Merchlinsky M., Moss B. Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression. J. Virol. 63:1989b;1595-1603.
45. Morgan J. R., Cohen L. K., Roberts B. E. Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus. J. Virol. 52:1984;206-214.
46. Moss B. Fields Virology. 1996;Lippincott-Raven, New York. p. 2637-2672.
47. Myette J. R., Niles E. G. Domain structure of the vaccinia virus mRNA capping enzyme: Expression inEscherichia coli. J. Biol. Chem. 271:1996;11936-11944.
48. Niles E. G., Christen L. Identification of the vaccinia virus mRNA guanyltransferase active site lysine. J. Biol. Chem. 268:1993;24986-24989.
49. Niles E. G., Condit R. C., Caro P., Davidson K., Matusick L., Seto J. Nucleotide sequence and genetic map of the 16-kb vaccinia virusHin. Virology. 153:1986;96-112.
50. Niles E. G., Lee Chen G. J., Shuman S., Moss B., Broyles S. S. Vaccinia virus gene D12L encodes the small subunit of the viral mRNA capping enzyme. Virology. 172:1989;513-522.
51. Niles E. G., Christen L., Higman M. A. Direct photolinkage of GTP to the vaccinia virus mRNA (guanine-7-) methyltransferase GTPmethyl acceptor site. Biochemistry. 33:1994;9898-9903.
52. Parsons B. L., Pickup D. J. Transcription of orthopoxvirus telomeres at late times during infection. Virology. 175:1990;69-80.
53. Rohrmann G., Moss B. Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions. J. Virol. 56:1985;349-355.
54. Schwer B., Shuman S. Conditional inactivation of mRNA capping enzyme affects yeast pre-mRNA splicingin vivo. RNA. 2:1996;574-583.
55. Shuman S. Catalytic activity of vaccinia mRNA capping enzyme subunits coexpressed inEscherichia coli. J. Biol. Chem. 265:1990;11960-11966.
56. Shuman S., Morham S. G. Domain structure of vaccinia virus mRNA capping enzyme. Activity of the Mr 95,000 subunit expressed inEscherichia coli. J. Biol. Chem. 265:1990;11967-11972.
57. Shuman S., Moss B. Purification and use of vaccinia virus messenger RNA capping enzyme. Methods Enzymol. 181:1990;170-180.
58. Shuman S., Broyles S. S., Moss B. Purification and characterization of a transcription termination factor from vaccinia virions. J. Biol. Chem. 262:1987;12372-12380.
59. Stuart D., Graham K., Schreiber M., Macaulay C., McFadden G. The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J. Virol. 65:1991;61-70.
60. Stuart D., Ellison K., Graham K., McFadden G. In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease. J. Virol. 66:1992;1551-1563.
61. Thompson C. L., Condit R. C. Marker rescue mapping of vaccinia virus temperature-sensitive mutants using overlapping cosmid clones representing the entire virus genome. Virology. 150:1986;10-20.
62. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
63. Traktman P. The enzymology of poxvirus DNA replication. Curr. Top. Microbiol. Immunol. 163:1990;93-124.
64. Turner P., Moyer R. A PCR based method for manipulation of the vaccinia virus genome that eliminates the need for cloning. Biotechniques. 13:1995;764-771.
65. Tutas D. J., Paoletti E. Purification and characterization of core-associated polynucleotide 5′-triphosphatase from vaccinia virus. J. Biol. Chem. 252:1977;3092-3098.
66. VanSlyke J. K., Whitehead S. S., Wilson E. M., Hruby D. E. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: A degenerate conserved cleavage motif within core proteins. Virology. 183:1991;467-478.
67. Venkatesan S., Gershowitz A., Moss B. Modification of the 5′ end of mRNA: Association of RNA triphosphatase with the RNA guanylyltransferase-RNA (guanine-7-)methyltransferase complex from vaccinia virus. J. Biol. Chem. 255:1980;903-908.
68. Vos J. C., Sasker M., Stunnenberg H. G. Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J. 10:1991;2553-2558.
69. Wertman K. F., Drubin D. G., Botstein D. Systematic mutational analysis of the yeast ACT1 gene. Genetics. 132:1992;337-350.
70. Yu L., Shuman S. Mutational analysis of the RNA triphosphatase component of vaccinia virus mRNA capping enzyme. J Virol. 70:1996;6162-6168.